Association of the triglyceride-glucose index combined with a body shape index with all-cause and cardiovascular mortality in individuals with cardiovascular-kidney-metabolic syndrome stage 0–3: findings from two prospective cohorts

Cardiovasc DiabetolPublished Prospective cohort study

Authors' conclusion

Among individuals with CKM stages 0-3, TyG-ABSI demonstrates a stronger association with mortality risk and superior predictive ability compared with other TyG-derived metrics. Its performance suggests a potential role in capturing variations across diverse clinical subgroups, and informing optimal timing for preventive interventions.

Study context

Population
Individuals with cardiovascular-kidney-metabolic syndrome (CKM) stages 0–3, NHANES cohort (1999–2018); external validation in CHARLSNHANES cohort
Participants
13,480 individuals
Exposure
Higher vs lower TyG-ABSI
Outcome
All-cause mortality and CVD mortality
Methodological detailstwo prospective cohorts, external validation in CHARLS, Cox proportional hazards models and restricted cubic spline functions
  • Two prospective cohorts
  • External validation in CHARLS
  • Cox proportional hazards models and restricted cubic spline functions

Main finding

As reported in the abstract

All-cause mortality, HR

1.226

95% CI 1.104–1.361

Cardiovascular mortality, HR

1.377

95% CI 1.149–1.651

Observational data: associations, not effects.

Further findings

Prognostic performance of TyG-ABSI (time-dependent ROC) · 5-15 years

AUC, all-cause mortality
0.688-0.708
AUC, cardiovascular mortality
0.696-0.739
More accurate long-term prognostic performance than other triglyceride-glucose (TyG)-derived metrics

External validation (CHARLS)

Confirmed robustness of findings in predicting all-cause mortality

Original publication

Association of the triglyceride-glucose index combined with a body shape index with all-cause and cardiovascular mortality in individuals with cardiovascular-kidney-metabolic syndrome stage 0–3: findings from two prospective cohorts. Cardiovasc Diabetol. Published 23 September 2025. doi:10.1186/s12933-025-02921-3

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.